v3.25.4
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Operating Activities      
Net Income (Loss) $ (1.2) $ 1.3 $ 69.4
Adjustments to reconcile net income (loss) to net cash provided (used) by operating activities:      
Depreciation and amortization 56.6 54.1 56.9
Amortization of deferred financing fees 0.4 0.5 0.5
Loss on extinguishment of debt 3.6 9.4 11.4
Loss (gain) on sale or disposal of assets, net (1.3) 0.6 (2.5)
Deferred income taxes 3.7 0.5 (9.7)
Stock-based compensation expense 14.7 14.0 11.5
Pension and postretirement (benefit) expense, net 10.1 14.4 47.1
Changes in operating assets and liabilities:      
Accounts receivable, net (34.7) 21.7 (33.4)
Inventories, net (22.9) 7.3 (34.9)
Accounts payable 29.1 (19.2) 15.3
Other accrued expenses 13.1 (21.7) 5.3
Deferred charges and prepaid expenses 3.5 (19.6) (3.9)
Pension and postretirement contributions and payments (64.1) (45.5) (2.8)
Other, net 5.4 22.5 (4.9)
Net Cash Provided (Used) by Operating Activities 16.0 40.3 125.3
Investing Activities      
Capital expenditures (109.0) (64.3) (51.6)
Proceeds from government funding 32.1 53.5 0.0
Proceeds from sale or disposals of property, plant and equipment 1.7 0.0 1.7
Net Cash Provided (Used) by Investing Activities (75.2) (10.8) (49.9)
Financing Activities      
Purchase of treasury shares (13.1) (37.6) (32.6)
Proceeds from exercise of stock options 0.0 1.4 2.8
Shares surrendered for employee taxes on stock compensation (2.6) (15.5) (3.4)
Repayments on convertible notes (9.1) (17.2) (18.7)
Principal payments under finance lease obligations (0.4) 0.0 0.0
Net Cash Provided (Used) by Financing Activities (25.2) (68.9) (51.9)
Increase (Decrease) in Cash, Cash Equivalents, and Restricted Cash (84.4) (39.4) 23.5
Cash, Cash Equivalents, and Restricted Cash at Beginning of Period 241.9 281.3 257.8
Cash, Cash Equivalents, and Restricted Cash at End of Period $ 157.5 $ 241.9 $ 281.3